Takeda’s dengue vaccine candidate offers protection against dengue fever in clinical trial
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
TAK-003 is currently undergoing regulatory review for potential licensure in both the European Union
New Director supports NASDAQ rule on diversity
Marinus has broadened inclusion criteria in the RAISE trial to allow for enrollment of patients previously treated with IV anesthesia.
The second phase of the orientation workshop is being organized to provide in-depth knowledge to the state officials on core building blocks of ABDM
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
Focussed campaigns for old age homes, schools/colleges, prisons, brick kilns to be taken up by States/UTs
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights how blockchain ensures the authenticity of products thereby, improves trust, traceability, and transparency across key sectors
The campaign aims to promote an integrated view by combining Ayurveda and Yoga to create harmony not just within the body, but also in our minds
Subscribe To Our Newsletter & Stay Updated